欢迎来到《四川大学学报(医学版)》

社交焦虑障碍认知行为治疗前后静息态局部一致性研究

Regional Homogeneity Changes in Patients with Social Anxiety Disorders after Cognitive Behavioral Therapy

  • 摘要: 目的 检测社交焦虑障碍(social anxiety disorder, SAD)患者认知行为治疗(cognitive behavior treatment, CBT)前后静息态大脑自发活动变化,探讨SAD形成、治疗和恢复的神经机制。方法 对15例SAD患者进行8周的团体CBT治疗,并在治疗前后对患者进行静息态功能磁共振扫描。纳入健康对照18例并进行基线水平的功能磁共振扫描。采用局部一致性(regional homogeneity,ReHo)分析并进行患者与对照的组间、患者治疗前后组内比较。在第一次MRI扫描之前对所有被试采用Liebowitz 社交焦虑量表 (LSAS)、汉密尔顿焦虑(HAMA)量表、汉密尔顿抑郁(HAMD)量表进行评估。患者组在心理治疗结束后的1周内进行第二次MRI扫描,并再次评估上述量表得分。所有被试均采用临床量表评估症状。结果 所有研究对象均为右利手。患者组男性11例,女性4例,平均年龄(27.07±8.11)岁,对照组男性13例,女性5例,平均年龄(26.28±2.42)岁。患者组与对照组间性别、年龄差异无统计学意义。量表LSAS、HAMA、HAMD在患者组和对照组之间差异有统计学意义(P<0.01),在8周的CBT之后患者组的临床量表得分较治疗前降低。和健康对照组相比,SAD患者治疗前右小脑后叶ReHo增高〔P<0.05,多重比较校正(GRF校正)〕,治疗后各脑区ReHo差异无统计学意义;SAD患者治疗前后自身比较显示左壳核、右尾状核ReHo增高(P<0.05,GRF校正)。治疗前后患者右小脑后叶平均ReHo的改变与Liebowitz 社交焦虑量表的恐惧分量的减分(ΔLSAS-fear)改变呈正相关(r=0.62, P=0.015)。结论 心理治疗可以通过恢复小脑异常的自发活动来达到减轻SAD临床症状的目的。小脑可能是认知行为治疗对于SAD治疗中调控疗效的一个潜在的生物学标记,这对更深入和全面探索SAD的病理生理机制提供了依据。

     

    Abstract: Objective To examine the altered spontaneous brain activity in patients with social anxiety disorders (SAD) before and after cognitive behavior therapy (CBT), and determine the neuromechanism of formation, treatment and recovery of SAD. Methods Fifteen SAD patients were treated with an eight-week group CBT. The patients underwent functional magnetic resonance imaging (fMRI) at resting state before and after the treatments. Eighteen healthy controls (HC) were recruited and underwent a baseline fMRI scan. The regional homogeneity (ReHo) of the patients was compared with the healthy controls. Before the baseline scanning, all participants were assessed with the Liebowitz Social Anxiety Scale(LSAS), the Hamilton Anxiety Rating Scale (HAMA) and the Hamilton Depression Rating Scale (HAMD). Results All participants were right-handed. 10 males and 4 females were in the patient group, with mean age of (27.07±8.11) years. 13 males and 5 females were in the HC group, with mean age of (26.28±2.42) years. There was no difference for gender and age while significant differences were found in LSAS,HAMA,HAMD between patients and controls (P<0.01). After 8 weeks of group CBT, clinical assessments significantly decreased (P<0.05) in patients group. Compared with HC, the pre-treatment SAD patients showed significantly increased ReHo in right cerebellum lobe at baseline 〔(P<0.05, with Gaussian random field (GRF) correction〕; but the difference became insignificant after the group CBT. The post-treatment patients showed increased ReHo in left putamen and right caudate compared with their pre-treatment conditions (P<0.05,with GRF correction). Pre-post ReHo change in right cerebellum posterior in patients was positively correlated with pre-post change of LSAS-fear scores (r=0.62, P=0.015). Conclusion The activity of cerebellum might be one of the potential biomakers to modulate the treatment effect of CBT in SAD, which provides a basis for further investigation into the pathophysiology of SAD.

     

/

返回文章
返回